Order Article Reprints

Sura S, Bupathi M, Morris V, Conkling P, Todoroff K, Bhanegaonkar A, Ike C. Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study. Current Oncology. 2025; 32(4):187. https://doi.org/10.3390/curroncol32040187

Sura, Sneha, Manojkumar Bupathi, Valerie Morris, Paul Conkling, Karen Todoroff, Abhijeet Bhanegaonkar, and Chiemeka Ike. 2025. "Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study" Current Oncology 32, no. 4: 187. https://doi.org/10.3390/curroncol32040187

Sura, S., Bupathi, M., Morris, V., Conkling, P., Todoroff, K., Bhanegaonkar, A., & Ike, C. (2025). Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study. Current Oncology, 32(4), 187. https://doi.org/10.3390/curroncol32040187